Article info
PDFStomach
Original article
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
- Correspondence to Professor Yon Hui Kim, New Experimental Therapeutics Branch, National Cancer Center of Korea, Ilsan, Goyang-si, Gyeonggi-do 410-769, Republic of Korea; yhkim{at}ncc.re.kr; Professor Han Liang, The University of Texas MD Anderson Cancer Center, Houston TX, 77030, USA; hliang1@mdanderson.org; and Professor Taesung Park, Seoul National University, Kwanak-ro, Kwanak-gu Seoul, 151-742, Republic of Korea; tspark@stats.snu.ac.kr
Citation
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
Publication history
- Received June 26, 2014
- Revised October 10, 2014
- Accepted October 25, 2014
- First published November 19, 2014.
Online issue publication
April 18, 2016
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/